The framework reads distribution. Smart money appears to be selling into strength. Institutional holders may be rotating out. Price has moved down 0.0% since our last review. Ethical screening: FAIL. This security does not pass our values-based screening criteria. The risk-adjusted return profile shows modest positive risk-adjusted returns. Our composite framework grades it C, carrying a low risk profile. Technically it is sitting below its long-term trend line with momentum reading neutral. Over the past year the shares are down 3%. Our forward projection puts the odds of a 10% gain over the next month near 23%. The street (25 analysts) rates it buy, with a mean price target of $270. It reported earnings in this window, a natural checkpoint for the thesis.
Boeing BA
Outside both standards
An entry written while the outcome is still unknown. It will be scored by what the market does next, and it will never be edited to look cleverer than it was.
In plain words · The Boeing Company, together with its subsidiaries, designs, develops, manufactures, sells, services, and supports commercial jetliners, military aircraft, satellites, missile defense, human space flight and launch syste…
read at $209.52
Boeing holds its Distribution at $209.52.
- PHPhase · the trend structure carries the Distribution label
- INInsiders · no filings inside 60 days, left as found
- POPositioning · no disclosures inside 60 days, left as found
- OPOptions · no verdict drawn today, left as found
- SCScreen · does not pass the values gate
- edge confirmed
- edge broken
- edge forming
Each arm is one independent read. Conviction is not a single call, it is how many edges converge.
The investor read · the season, not the day
| Phase | Distribution · caution |
| Quantitative state | Consolidating, no directional conviction, held for 119 days |
| Price | $209.52 |
| Valuation | 82.81 trailing · 51.05 forward price to earnings |
| Values screen | FAIL · score 10.0 |
| Beta | 1.21 |
The opportunity · what the numbers say it is worth
Our framework reads AVOID — it trades above our $177.29 fair value estimate, weak competitive moat, 14.00% revenue growth.
Price history & projections · where it has been, where the models see it going
The valuation journey · where the price sits against fair value and the Street
Green marks levels above today's price, red below; the shaded band is the gap between the price and our fair value.
Reading the gap · Our more conservative model reads it as fully-to-richly valued here, while the Street is more bullish — a quality-at-a-fair-price name rather than a deep-value one.
| Revenue growth | 14.00% |
| Profit margin | 2.46% |
| Debt to equity | 828.70 |
| Analyst consensus | Buy · 26 covering |
Fair value and rating are our own model estimates; target range reflects third-party analyst estimates. Analysis, not advice.
The values screen, explained · five checks, plain English
This company is excluded by both standards. There are two widely recognised ways to check whether a company is suitable for a Muslim investor. It fails on both:
Used by most halal investing apps ✗ DOES NOT PASS
The one Titan applies ✗ DOES NOT PASS
Why it fails. The problem is its business activity screen. Because both standards agree on this, it is a clear exclusion, not a borderline case.
What these two standards are, and how they differ →
- Business activity Business activity: Aerospace & Defense Fail
Every security is read against two recognised standards: our stricter asset-based screen (ratios measured against total assets) and the more widely used market-value standard (measured against market capitalisation). Where they agree we say so plainly; where they part ways — almost always on the debt check — we show both readings and mark it, because that disagreement is the finding, not a fault. We report the score; you and your scholar make the call.
The business, in plain words · what the numbers mean
Boeing looks loved yet we pass
Boeing sits at the centre of every airport and defence budget, yet the shares trade at 214 dollars against our fair value of 177. The forward multiple sits at 52 times earnings while margins scrape just 2 percent and the moat looks weak. On top of that the business fails our ethical screen, so we step away.
Revenue is growing 14 percent but the price already bakes in perfection and then some. Return on equity prints 170 percent, yet that figure rests on a thin equity base and does not change the valuation gap or the ethical red flag. Twenty-six analysts call it a buy with a 272 dollar median target; none of that moves our view.
Risk sits in the premium paid for a cyclical name that carries both defence exposure and stretched multiples. When sentiment turns, the gap to fair value can close fast and painfully. Analysis, not advice.
| Forward P/E | 51.0x expensive even after accounting for its growth |
| Trailing P/E | 82.8x expensive — the price assumes strong growth ahead |
| Revenue growth | 14.0% steady growth |
| Profit margin | 2.5% barely profitable |
| Return on equity | 169.9% an exceptional return on shareholder capital |
| Debt to equity | 8.29 heavy leverage — higher risk if revenue softens |
| Current ratio | 1.18 adequate liquidity, worth monitoring |
| Beta | 1.21 moves a little more than the market |
| Market cap | $165.2B |
| Employees | 182,000 |
The risks · The things to watch: it carries a real debt load, which raises the stakes if revenue slips.
Plain-English interpretation of our own screen data. Analysis, not advice.
Latest news · what the market is reading on BA
- › Rocket Lab Lands Launch Contract, Space Force Taps Vendors For $981 Million Program Investor's Business Daily · 2d ago
- › Boeing’s $21 billion B-52 upgrade faces cost overruns, delays, GAO says Investing.com · 2d ago
- › Hexcel Q2 Earnings Call Highlights MarketBeat · 2d ago
- › The U.S. Just Took A Big Step to Break China's Magnet Dominance Oilprice.com · 3d ago
- › Hexcel Corp (HXL) (Q2 2026) Earnings Call Highlights: Strong Sales Growth and Raised Guidance ... GuruFocus.com · 3d ago
Headlines from third-party outlets, linked for reference — not our reporting, not advice.
Related securities · others in BA's space worth a look
Screened names in the same industry · explore each on its own page.
Where & how to trade · wherever in the world you are
BA trades on a US exchange. As a US-listed security it is accessible through almost any international broker offering US markets. New to this, or investing from outside the US? Our guide to accessing global markets covers brokers, currencies and the practical steps.
The trader read · the latest dated commentary
The dated journal · newest first, never edited
The framework reads distribution. Smart money appears to be selling into strength. Institutional holders may be rotating out. Price has moved down 0.0% since our last review. Ethical screening: FAIL. This security does not pass our values-based screening criteria. The risk-adjusted return profile shows modest positive risk-adjusted returns. Our composite framework grades it C, carrying a low risk profile. Technically it is sitting below its long-term trend line with momentum reading neutral. Over the past year the shares are down 3%. Our forward projection puts the odds of a 10% gain over the next month near 23%. The street (25 analysts) rates it buy, with a mean price target of $270. It reported earnings in this window, a natural checkpoint for the thesis.
The framework reads distribution. Smart money appears to be selling into strength. Institutional holders may be rotating out. Price has moved down 0.0% since our last review. Ethical screening: FAIL. This security does not pass our values-based screening criteria. The risk-adjusted return profile shows modest positive risk-adjusted returns. Our composite framework grades it C, carrying a low risk profile. Technically it is sitting below its long-term trend line with momentum reading neutral. Over the past year the shares are down 3%. Our forward projection puts the odds of a 10% gain over the next month near 23%. The street (25 analysts) rates it buy, with a mean price target of $270. It reported earnings in this window, a natural checkpoint for the thesis.
The framework reads distribution. Smart money appears to be selling into strength. Institutional holders may be rotating out. Price has moved down 2.1% since our last review. Ethical screening: FAIL. This security does not pass our values-based screening criteria. The risk-adjusted return profile shows modest positive risk-adjusted returns. Our composite framework grades it C, carrying a low risk profile. Technically it is sitting below its long-term trend line with momentum reading neutral. Over the past year the shares are down 3%. Our forward projection puts the odds of a 10% gain over the next month near 23%. The street (25 analysts) rates it buy, with a mean price target of $270. It reported earnings in this window, a natural checkpoint for the thesis.
The framework reads distribution. Smart money appears to be selling into strength. Institutional holders may be rotating out. Price has moved down 0.0% since our last review. Ethical screening: FAIL. This security does not pass our values-based screening criteria. The risk-adjusted return profile shows modest positive risk-adjusted returns. Our composite framework grades it C, carrying a low risk profile. Technically it is sitting below its long-term trend line with momentum reading neutral. Over the past year the shares are down 3%. Our forward projection puts the odds of a 10% gain over the next month near 23%. The street (25 analysts) rates it buy, with a mean price target of $270. It reported earnings in this window, a natural checkpoint for the thesis.
The framework reads distribution. Smart money appears to be selling into strength. Institutional holders may be rotating out. Price has moved down 0.0% since our last review. Ethical screening: FAIL. This security does not pass our values-based screening criteria. The risk-adjusted return profile shows modest positive risk-adjusted returns. Our composite framework grades it C, carrying a low risk profile. Technically it is sitting below its long-term trend line with momentum reading neutral. Over the past year the shares are down 3%. Our forward projection puts the odds of a 10% gain over the next month near 23%. The street (25 analysts) rates it buy, with a mean price target of $270. It reported earnings in this window, a natural checkpoint for the thesis.
The framework reads distribution. Smart money appears to be selling into strength. Institutional holders may be rotating out. Price has moved down 0.0% since our last review. Ethical screening: FAIL. This security does not pass our values-based screening criteria. The risk-adjusted return profile shows modest positive risk-adjusted returns. Our composite framework grades it C, carrying a low risk profile. Technically it is sitting below its long-term trend line with momentum reading neutral. Over the past year the shares are down 3%. Our forward projection puts the odds of a 10% gain over the next month near 23%. The street (25 analysts) rates it buy, with a mean price target of $270. It reported earnings in this window, a natural checkpoint for the thesis.
The framework reads distribution. Smart money appears to be selling into strength. Institutional holders may be rotating out. Price has moved down 0.7% since our last review. Ethical screening: FAIL. This security does not pass our values-based screening criteria. The risk-adjusted return profile shows modest positive risk-adjusted returns. Our composite framework grades it C, carrying a low risk profile. Technically it is sitting below its long-term trend line with momentum reading neutral. Over the past year the shares are down 3%. Our forward projection puts the odds of a 10% gain over the next month near 23%. The street (25 analysts) rates it buy, with a mean price target of $270. It reported earnings in this window, a natural checkpoint for the thesis.
The framework reads distribution. Smart money appears to be selling into strength. Institutional holders may be rotating out. Price has moved down 0.0% since our last review. Ethical screening: FAIL. This security does not pass our values-based screening criteria. The risk-adjusted return profile shows modest positive risk-adjusted returns. Our composite framework grades it C, carrying a low risk profile. Technically it is sitting below its long-term trend line with momentum reading neutral. Over the past year the shares are down 3%. Our forward projection puts the odds of a 10% gain over the next month near 23%. The street (25 analysts) rates it buy, with a mean price target of $270.
The framework reads distribution. Smart money appears to be selling into strength. Institutional holders may be rotating out. Price has moved down 0.0% since our last review. Ethical screening: FAIL. This security does not pass our values-based screening criteria. The risk-adjusted return profile shows modest positive risk-adjusted returns.
Each entry above was written on its date, before the outcome. A journal you can prune is not a journal.
The insider ledger · Form 4 filings, as filed
| Date | Insider | Title | Type | Shares | Value |
|---|---|---|---|---|---|
| 2026-03-03 | BUCKLEY MORTIMER J. | Director | 2,230 | $499,966 | |
| 2026-02-24 | AMULURU UMA M | Officer | 1,503 | $351,484 | |
| 2026-02-17 | MALAVE JESUS JR. | Chief Financial Officer | 18,788 | · | |
| 2026-02-17 | POPE STEPHANIE F | Officer | 28,904 | · | |
| 2026-02-17 | NELSON BRENDAN J. | Officer | 5,058 | · | |
| 2026-02-17 | MCKENZIE HOWARD E | Officer | 9,248 | · | |
| 2026-02-17 | CLEARY MICHAEL J | Officer | 3,721 | · | |
| 2026-02-17 | GERRY BRETT C. | Officer | 13,006 | · | |
| 2026-02-17 | RAYMOND DAVID CHRISTOPHER | Officer | 7,515 | · | |
| 2026-02-17 | AMULURU UMA M | Officer | 9,826 | · |
Public filings, recorded as found. The full tape lives at Insider Intelligence.
The political ledger · congressional disclosures
| Date | Politician | Party | Type | Amount |
|---|---|---|---|---|
| 9 Jun2026 | Gil Cisneros | Democrat | buy | 1K–15K |
| 9 Jun2026 | Gil Cisneros | Democrat | buy | 1K–15K |
| 9 Apr2026 | Josh Gottheimer | Democrat | sell | 1K–15K |
| 7 Feb2025 | Tim Walberg | Republican | buy | 15K–50K |
| 7 Feb2025 | Tim Walberg | Republican | buy | 15K–50K |
What holding actually paid · price plus dividends
| Period | Price then | Price return | Divs per share | $1,000 became | Total return |
|---|---|---|---|---|---|
| 1 month | $238.21 | -12.3% | · | $877 | -12.3% |
| 2 months | $217.63 | -4.0% | · | $960 | -4.0% |
| 3 months | $204.76 | +2.0% | · | $1,020 | +2.0% |
| 6 months | $200.71 | +4.1% | · | $1,041 | +4.1% |
| 1 year | $215.73 | -3.2% | · | $968 | -3.2% |
| 2 years | $190.12 | +9.9% | · | $1,099 | +9.9% |
| 3 years | $217.31 | -3.9% | · | $961 | -3.9% |
| 5 years | $247.28 | -15.6% | · | $845 | -15.6% |
Historical returns from market close data. Past performance does not guarantee future results.